Your career starts on Magnet.me
Create a profile and receive smart job recommendations based on your liked jobs.
Pleased to meet you, we are Galapagos, a biotechnology company with operations in Europe and the U.S. dedicated to developing transformational medicines for more years of life and quality of life.
We are in the business of changing lives. Focusing on high unmet medical needs, we synergize compelling science, technology, and collaborative approaches to create a deep pipeline of best-in-class small molecules, CAR-T therapies and biologics in oncology and immunology. With capabilities from lab to patient, including a decentralized CAR-T manufacturing network, we are committed to challenging the status quo and delivering results for our patients, employees and shareholders.
We are looking for a Senior Process Engineer Global MSAT Contractor to join our team in Leiden for a period of 6 months.
We are seeking a Senior Process Engineer Global MSAT to join the team in the Leiden Bio Science Park, The Netherlands. The Senior Process Engineer is an experienced subject matter expert on automated CAR-T manufacturing processes and technology transfers in a decentralized manufacturing model, who drives the progress and development of the CAR-T manufacturing processes/products from early clinical stage through pivotal/commercial readiness.
The Senior Process Engineer reports to the Director Process Engineering Global MSAT.
Who are you?
At Galapagos, we are committed to building meaningful partnerships with our consultants, offering a collaborative and supportive environment where you are recognized as an integral part of the team. As a consultant, you will engage in a variety of projects, enabling you to expand your expertise across multiple domains. Our aim is to support your professional growth while fostering a dynamic workplace that values and empowers you as an equal partner.
Galapagos is a clinical-stage biotechnology company specialized in the discovery and development of small molecule medicines with novel modes of action. Galapagos’ pipeline comprises Phase 3 through to discovery programs in cystic fibrosis, inflammation, fibrosis, osteoarthritis and other indications.
Change language to: Dutch
This page is optimised for people from the Netherlands. View the version optimised for people from the UK.